Patent | Date |
---|
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20220211692 - Hardee; David J. ;   et al. | 2022-07-07 |
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20210238159 - Altenbach; Robert J. ;   et al. | 2021-08-05 |
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,988,454 - Altenbach , et al. April 27, 2 | 2021-04-27 |
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,981,890 - Altenbach , et al. April 20, 2 | 2021-04-20 |
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,844,041 - Altenbach , et al. November 24, 2 | 2020-11-24 |
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,844,042 - Altenbach , et al. November 24, 2 | 2020-11-24 |
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,829,473 - Altenbach , et al. November 10, 2 | 2020-11-10 |
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20200277273 - Altenbach; Robert J. ;   et al. | 2020-09-03 |
Modulators Of The Cystic Fibrosis Transmembrane Conductance Regulator Protein And Methods Of Use App 20200277275 - Altenbach; Robert J. ;   et al. | 2020-09-03 |
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20200277276 - Altenbach; Robert J. ;   et al. | 2020-09-03 |
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20200277274 - Altenbach; Robert J. ;   et al. | 2020-09-03 |
Substituted Pyrrolidines and Methods of Use App 20190315687 - Altenbach; Robert J. ;   et al. | 2019-10-17 |
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use Grant 10,428,017 - Altenbach , et al. October 1, 2 | 2019-10-01 |
Substituted Tricyclics and Method of Use App 20190135827 - Altenbach; Robert J. ;   et al. | 2019-05-09 |
Substituted Chromanes and Method of Use App 20190127356 - Altenbach; Robert J. ;   et al. | 2019-05-02 |
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20190077784 - Altenbach; Robert J. ;   et al. | 2019-03-14 |
Modulators of cystic fibrosis transmembrane conductance regulator protein Grant 10,118,916 - Altenbach , et al. November 6, 2 | 2018-11-06 |
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20180244640 - Altenbach; Robert J. ;   et al. | 2018-08-30 |
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use App 20180244611 - Altenbach; Robert J. ;   et al. | 2018-08-30 |
Substituted Tricyclics and Method of Use App 20180037587 - Altenbach; Robert J. ;   et al. | 2018-02-08 |
Substituted tricyclics and method of use Grant 9,840,513 - Altenbach , et al. December 12, 2 | 2017-12-12 |
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator Protein App 20170305891 - Altenbach; Robert J. ;   et al. | 2017-10-26 |
Substituted Chromanes And Method Of Use App 20170190693 - Altenbach; Robert J. ;   et al. | 2017-07-06 |
Substituted chromanes and method of use Grant 9,642,831 - Altenbach , et al. May 9, 2 | 2017-05-09 |
Substituted tetrahydropyrans and method of use Grant 9,567,322 - Kym , et al. February 14, 2 | 2017-02-14 |
Substituted Tricyclics And Method Of Use App 20170015675 - Altenbach; Robert J. ;   et al. | 2017-01-19 |
Substituted Chromanes And Method Of Use App 20160120841 - Kym; Philip R. ;   et al. | 2016-05-05 |
Substituted Tetrahydropyrans And Method Of Use App 20160122331 - Kym; Philip R. ;   et al. | 2016-05-05 |
Substituted octahydrocyclopenta[c]pyrroles as calcium channel modulators Grant 8,796,470 - Searle , et al. August 5, 2 | 2014-08-05 |
Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers Grant 8,691,865 - Searle , et al. April 8, 2 | 2014-04-08 |
Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers Grant 8,129,417 - Stewart , et al. March 6, 2 | 2012-03-06 |
SUBSTITUTED OCTAHYDROCYCLOPENTA[c]PYRROLES AS CALCIUM CHANNEL MODULATORS App 20110294854 - Searle; Xenia B. ;   et al. | 2011-12-01 |
Novel Substituted Octahydrocyclopenta[c]pyrrol-4-amines As Calcium Channel Blockers App 20110281870 - Searle; Xenia B. ;   et al. | 2011-11-17 |
Antibacterial compounds Grant 7,737,159 - Anderson , et al. June 15, 2 | 2010-06-15 |
Novel Substituted Octahydrocyclopenta[c]pyrrol-4-amines As Calcium Channel Blockers App 20100130558 - Stewart; Andrew O. ;   et al. | 2010-05-27 |
Antibacterial Compounds App 20070142353 - Anderson; David D. ;   et al. | 2007-06-21 |
Antibacterial compounds Grant 7,196,200 - Anderson , et al. March 27, 2 | 2007-03-27 |
Azabicyclic compounds are central nervous system active agents App 20060287290 - Dart; Michael J. ;   et al. | 2006-12-21 |
Azabicyclic compounds are central nervous system active agents Grant 7,135,484 - Dart , et al. November 14, 2 | 2006-11-14 |
Antibacterial compounds App 20050159423 - Anderson, David D. ;   et al. | 2005-07-21 |
Azabicyclic compounds are central nervous system active agents App 20040152724 - Dart, Michael J. ;   et al. | 2004-08-05 |
3-Amino-2-hydroxyalkanoic acids and their prodrugs App 20040122098 - BaMaung, Nwe Y. ;   et al. | 2004-06-24 |
Azabicyclic compounds are central nervous system active agents App 20040044029 - Dart, Michael J. ;   et al. | 2004-03-04 |